EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analysis of Risk Factors for Post-ERCP Pancreatitis in Patients with Cholangiocarcinoma

Takeshi Iizuka iD, Yusuke Kurita iD, Yu Honda, Takayuki Oda, Shin Yagi, Sho Hasegawa, Takamitsu Sato, Kunihiro Hosono iD, Noritoshi Kobayashi iD, Itaru Endo iD, Kensuke Kubota, Masato Yoneda iD

Diagnostics · 18.03.2026 · 16 (6) · 900

DOI: 10.3390/diagnostics16060900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 18.03.2026. Verfasst von Takeshi Iizuka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Yokohama City University Hospital, Yokohama 236-0004, Kanagawa, Japan. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Endoscopic retrograde cholangiopancreatography (ERCP) is commonly performed for cholangiocarcinoma and often involves multiple procedures, potentially increasing the risk of post-ERCP pancreatitis (PEP). However, PEP characteristics in cholangiocarcinoma patients remain unclear. This study aimed to assess the incidence and diagnostic procedure-specific risk factors for PEP in patients with cholangiocarcinoma.

Methods

We retrospectively reviewed 218 ERCP procedures for cholangiocarcinoma performed at our hospital between January 2017 and March 2022. The incidence of PEP, severe PEP, and fatal PEP was recorded. Risk factors for PEP were analyzed using multivariate analysis, and severe cases were further evaluated.

Results

Among the 218 patients, 15 (6.9%) developed PEP, 4 (1.8%) had severe PEP, and 2 (0.9%) died. Multivariate analysis identified the pancreatic guidewire technique (PGW) (OR: 8.18; 95% CI: 2.52–26.53, p < 0.001) and intraductal ultrasonography (IDUS) (OR: 6.53; 95% CI: 2.01–21.25, p = 0.002) as significant risk factors. Both fatal cases involved naïve papilla and PGW and IDUS, with no pancreatic duct stent placement.

Conclusions

ERCP for cholangiocarcinoma carries a clinically relevant risk of severe or fatal PEP. In particular, ERCP-specific diagnostic procedures required for cholangiocarcinoma may confer a disease-specific risk profile distinct from that of general ERCP. PGW and IDUS were identified as major risk factors, especially in patients with a naïve papilla, in whom prophylactic pancreatic duct stenting should be considered to reduce the risk of severe or fatal outcomes.

Schlagwörter

Stichwörter der Autor:innen

cholangiocarcinomaendoscopic retrograde cholangiopancreatographyoutcomespost-ERCP pancreatitisrisk factors

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Yokohama City University Hospital, Yokohama 236-0004, Kanagawa, Japan.
  • Department of Oncology, Yokohama City University Hospital, Yokohama 236-0004, Kanagawa, Japan.
  • Department of Gastroenterological Surgery, Yokohama City University Hospital, Yokohama 236-0004, Kanagawa, Japan.

ORCID-Profile: Takeshi Iizuka, Yusuke Kurita, Kunihiro Hosono, Noritoshi Kobayashi, Itaru Endo, Masato Yoneda

Zitieren

APA

Iizuka, T., Kurita, Y., Honda, Y., Oda, T., Yagi, S., Hasegawa, S., Sato, T., Hosono, K., Kobayashi, N., Endo, I., Kubota, K., & Yoneda, M. (2026). Analysis of Risk Factors for Post-ERCP Pancreatitis in Patients with Cholangiocarcinoma. Diagnostics, 16(6), 900. https://doi.org/10.3390/diagnostics16060900

Vancouver

Iizuka T, Kurita Y, Honda Y, Oda T, Yagi S, Hasegawa S, et al. Analysis of Risk Factors for Post-ERCP Pancreatitis in Patients with Cholangiocarcinoma. Diagnostics. 2026;16(6):900. doi:10.3390/diagnostics16060900

BibTeX
@article{Iizuka2026,
  author = {Iizuka, Takeshi and Kurita, Yusuke and Honda, Yu and Oda, Takayuki and Yagi, Shin and Hasegawa, Sho and Sato, Takamitsu and Hosono, Kunihiro and Kobayashi, Noritoshi and Endo, Itaru and Kubota, Kensuke and Yoneda, Masato},
  title = {Analysis of Risk Factors for Post-ERCP Pancreatitis in Patients with Cholangiocarcinoma},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {900},
  doi = {10.3390/diagnostics16060900}
}
Kostenlos starten →